Company Research Report: Qure.ai Technologies Private Limited
1. Company Overview
- Name: Qure.ai Technologies Private Limited
- Mission: To use artificial intelligence to make healthcare more accessible and affordable.
- Founded: 2016
- Founders: Prashant Warier and Pooja Rao
- Headquarters: Mumbai, Maharashtra, India
- Number of Employees: 51-200
- Revenue: No information is available
- Key People:
- Prashant Warier - Founder & CEO
- Ankit Modi - Chief Product Officer
- Anushree Saha - General Counsel & Company Secretary
- Anumeha Srivastava - Chief Business Officer, Neurology
- Bhargava Reddy - Chief Business Officer, Oncology
- Bunty Kundnani - Chief Regulatory Affairs Officer
- Dara Kelleher - VP, Business Development - Global Health
- Divya Gupta - Chief Business Officer, Global Health
- Dr. Shibu Vijayan - Chief Medical Officer - Global Health
- Harsh Vaish - Chief Financial Officer
- Kaitik Shah - VP, Finance
- Kautuk Trivedi - Director, Design
- Poonam Ajgaonkar - Chief People Officer
- Pradeep Kumar Thummala - Head of Engineering
- Preetham Putha - Chief AI Officer
- Surabhi Srivastava - VP, Business Development - UK
- Notable Recognition: World's most adopted healthcare AI with over +1 billion data sets and +0 million lives impacted in 2600+ sites across 90+ countries.
- Known For: Leveraging deep learning and AI technology to provide automated interpretation of radiology exams (X-rays, CTs, Ultrasounds) and innovating in healthcare AI.
2. Products and Solutions
Core Products
1. Chest X-Ray Reporting
- Description: AI solution for comprehensive interpretation of Chest X-rays (qXR).
- Key Features:
- Reduces turnaround time for reporting.
- High Negative Predictive Value (NPV) for segregating unremarkable CXRs.
- Multilingual support.
- Automatic report generation.
- Capable of detecting various lung conditions including tuberculosis and lung nodules.
2. TB Care Cascades
- Description: AI-powered tool for tuberculosis screening and case management (qTrack).
- Key Features:
- Supports all major CR, DR and ultraportable X-rays.
- Provides real-time notifications.
- Reduces time to confirmed diagnosis.
- Multilingual support and flexibility for on-cloud or on-premises deployment.
3. Lung Nodule Management
- Description: AI solutions for early detection and monitoring of lung nodules.
- Key Features:
- Automated discordance framework for uninterrupted workflow.
- Generates Lung Nodule Malignancy Risk Score.
- Compatible with standard imaging guidelines.
- Precise volumetric measurement and characterisation features.
4. Stroke & TBI
- Description: AI solution for enhancing stroke care and early diagnostics (qER).
- Key Features:
- Reduces door-to-treatment time.
- AI-powered real-time communication tools for stroke management.
- Seamless integration and data sharing capabilities.
- FDA cleared for detection of intracranial hemorrhage and other critical findings.
5. MSK X-Ray Reporting
- Description: AI assistant for trauma musculoskeletal X-rays (qMSK).
- Key Features:
- Identifies subtle fractures.
- Offers bounding box visual aid for radiologists.
- Reduces diagnostic errors.
- Supports multiple views.
6. Heart Failure Screening
- Description: AI tool for incidental detection of heart failure risks on Chest X-rays (qXR-HF).
- Key Features:
- Real-time high precision notifications.
- High sensitivity for cardiomegaly and pleural effusion.
- Integrates seamlessly with major X-ray systems.
7. Qure AI App
- Description: Centralized platform for accessing Qure's AI solutions.
- Key Features:
- Seamless collaboration and pre-read assistance.
- Customizable workflows.
- Mobile support for on-the-go usage.
3. Recent Developments
Recent News and Collaborations
1. Strategic Radiology Collaboration
- Date: June 18, 2024
- Description: Partnership with Strategic Radiology to advance clinical accuracy and operational efficiency with AI-integrated imaging solutions bringing tech closer to 1700 radiologists.
2. FDA Approvals
- Recent Clearance: 13th FDA clearance for qXR-LN, the only FDA-cleared solution for detecting and localizing lung nodules using computer vision.
- Other Approvals:
- Heart failure detection on chest X-rays.
- Pneumothorax and pleural effusion detection, among others.
3. Global Expansion and Awards
- Recent Wins:
- Siemens Healthineers Startup Award 2024.
- Class III medical device license from Health Canada.
Partnerships and Projects
1. Collaborations with AstraZeneca
- Purpose: To bring AI solutions for early detection of lung cancer across India and other emerging markets.
- Outcomes: Enhancing early referral and diagnostic pathway, especially targeting underserved communities.
2. Medtronic Partnership
- Focus: Advanced stroke management.
- Achievements: Rapid deployment of AI solutions within critical care for faster clinical decision-making.
3. India Health Fund Collaboration
- Initiatives: Extensive TB screening and tuberculosis care enhancement across 20 states in India.
- Impact: Screened over 100,000 individuals; notable improvements in TB management efficiency.
4. AI Deployments in Disaster Management
- Applications: Incorporated AI tools for swift emergency response during pandemics like COVID-19, supporting real-time diagnostics.
In completion of this report, Qure.ai Technologies Private Limited stands out as a leader in healthcare AI, with clear progress in expanding clinical capabilities, regulatory milestones, and impactful partnerships for global health advancements.